# Ticagrelor and Endothelial Function

> **NCT02261922** · PHASE4 · UNKNOWN · sponsor: **Hotel Dieu de France Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Antiplatelet Agents; Endothelial Function; Pleotropic Effects

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** prasugrel

## Key facts

- **NCT ID:** NCT02261922
- **Lead sponsor:** Hotel Dieu de France Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02261922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02261922, "Ticagrelor and Endothelial Function". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02261922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*